38284-47-8 Usage
Description
(1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine is a complex organic compound with a unique molecular structure. It is characterized by its chiral centers at the 1st, 2nd, and 5th positions, as well as its morpholine ring. (1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine also features a 6,6-dimethylbicyclo[3.1.1]hept-2-yl group, which contributes to its structural complexity and potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
(1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine is used as a key intermediate in the synthesis of Pinaverium Bromide (P465000), a drug specifically designed to treat functional gastrointestinal disorders. (1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine plays a crucial role in the development of medications that help alleviate symptoms associated with these conditions, such as abdominal pain, bloating, and irregular bowel movements.
Check Digit Verification of cas no
The CAS Registry Mumber 38284-47-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,2,8 and 4 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 38284-47:
(7*3)+(6*8)+(5*2)+(4*8)+(3*4)+(2*4)+(1*7)=138
138 % 10 = 8
So 38284-47-8 is a valid CAS Registry Number.
InChI:InChI=1/C17H31NO2/c1-17(2)15-4-3-14(16(17)13-15)5-9-19-10-6-18-7-11-20-12-8-18/h14-16H,3-13H2,1-2H3
38284-47-8Relevant articles and documents
A synthesis method of pinaverium bromide
-
, (2018/11/04)
The invention relates to a pinaverium bromide synthesis method. Cheap and easily available morpholine as a raw material and an acylating agent undergo a reaction to produce a novel intermediate and pinaverium bromide is synthesized from the intermediate under mild conditions. Raw material reaction is complete, side reaction is less, the pinaverium bromide has treatment cis-isomeride content greater than or equal to 99% and trans-isomer content less than or equal to 1%, and product cis-isomer content is greatly improved.